Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. James W. Zimbler | Chief Executive Officer | -- | -- | 1966 |
| Mr. Gregory McCauley | Corporate Counsel | -- | -- | -- |
| Mr. Marvin Segel | Director & CMO | -- | -- | -- |
Emergent Health Corp
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, and various other retail outlets throughout the United States and internationally. Emergent Health Corp. was incorporated in 2006 and is based in King of Prussia, Pennsylvania. As of August 26, 2014, Emergent Health Corp was taken private.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
February 7, 2023 at 12:00 AM UTC
253G2: Reflects information that constitutes a substantive change from or addition to the information set forth in the last offering circular
January 12, 2023 at 12:00 AM UTC
253G1: Reflects information previously omitted from the offering circular in reliance on Rule 253(b)
January 5, 2023 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
November 23, 2022 at 12:00 AM UTC
253G1: Reflects information previously omitted from the offering circular in reliance on Rule 253(b)
November 18, 2022 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission